These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26925849)

  • 1. Enhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with transcutol P.
    Lee SG; Kang JB; Kim SR; Kim CJ; Yeom DW; Yoon HY; Kwak SS; Choi YW
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1636-42. PubMed ID: 26925849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis.
    Gabriel D; Mugnier T; Courthion H; Kranidioti K; Karagianni N; Denis MC; Lapteva M; Kalia Y; Möller M; Gurny R
    J Control Release; 2016 Nov; 242():16-24. PubMed ID: 27639683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus-loaded chitosan-based nanoparticles as an efficient topical therapeutic for the effective treatment of atopic dermatitis symptoms.
    Lee JS; Oh E; Oh H; Kim S; Ok S; Sa J; Lee JH; Shin YC; Bae YS; Choi CY; Lee S; Kwon HK; Yang S; Choi WI
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):133005. PubMed ID: 38866268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
    Jain S; Addan R; Kushwah V; Harde H; Mahajan RR
    Int J Pharm; 2019 May; 562():96-104. PubMed ID: 30902706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
    Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
    J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis.
    Bos JD
    Eur J Dermatol; 2003; 13(5):455-61. PubMed ID: 14693489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
    Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
    Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
    Rico MJ; Lawrence I
    Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature.
    Pustisek N; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2002 Mar; 10(1):25-32. PubMed ID: 12137728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects.
    Wang Y; Cao S; Yu K; Yang F; Yu X; Zhai Y; Wu C; Xu Y
    Int J Nanomedicine; 2019; 14():5849-5863. PubMed ID: 31440050
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR
    Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies.
    Panchagnula R; Ritschel WA
    J Pharm Pharmacol; 1991 Sep; 43(9):609-14. PubMed ID: 1685517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N; Kircik L
    J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation.
    Li G; Fan Y; Fan C; Li X; Wang X; Li M; Liu Y
    Eur J Pharm Biopharm; 2012 Sep; 82(1):49-57. PubMed ID: 22705640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.
    Simon D; Vassina E; Yousefi S; Kozlowski E; Braathen LR; Simon HU
    J Allergy Clin Immunol; 2004 Oct; 114(4):887-95. PubMed ID: 15480330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.